Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

The EMBO Journal
S S HongP A Boulanger

Abstract

Adenovirus serotype 5 (Ad5) fiber receptor was investigated using reverse antibody biopanning of a phage-displayed hexapeptide library, and virus-neutralizing monoclonal antibodies (mAbs 1D6.3 and 7A2.7) raised against recombinant Ad5 fiber knob. Both mAbs inhibited attachment of Ad5 to HeLa cells. Mimotopes of 1D6.3 showed homology with the C-terminal segment of the alpha2 domain of the heavy chain of human MHC class I molecules (MHC-I alpha2), and mimotopes of 7A2.7 were consensus to human fibronectin type III (FNIII) modules. In vitro, GST-fused MHC-I alpha2- and FNIII-derived oligopeptides interacted with recombinant fibers in a subgroup-specific manner. In vivo, the MHC-I alpha2 synthetic icosapeptide RAIVGFRVQWLRRYFVNGSR showed a net neutralization effect on Ad5 in HeLa cells, whereas the FNIII icosapeptide RHILWTPANTPAMGYLARVS significantly increased Ad5 binding to HeLa cells. Daudi cells, which lack surface expression of HLA class I molecules, showed a weak capacity for Ad5 binding. In beta2-microglobulin-transfected Daudi cells, Ad5 attachment and permissivity were restored to HeLa cell levels, with 4000 receptors per cell and a binding constant of 1.4x10(10)/M. The results suggested that the conserved region of MHC-I ...Continue Reading

References

Feb 26, 1976·Nature·K Lonberg-HolmL Philipson
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 15, 1977·The Biochemical Journal·B Hennache, P Boulanger
Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P Bork, R F Doolittle
Jul 27, 1990·Science·J K Scott, G P Smith
Nov 1, 1991·Journal of Virology·M J VargaE Everitt
Aug 2, 1990·Nature·T A Springer
Jan 1, 1990·Annual Review of Biochemistry·P J Bjorkman, P Parham
Mar 1, 1988·The Journal of General Virology·G WatsonW C Russell
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W R Pearson, D J Lipman
Oct 1, 1969·Journal of Virology·K Lonberg-Holm, L Philipson
Oct 1, 1968·Journal of Virology·L PhilipsonU Pettersson
Jan 30, 1982·Virology·M L Boudin, P Boulanger
Sep 1, 1984·Journal of Virology·U Svensson, R Persson
Oct 1, 1994·The Journal of Cell Biology·T J WickhamG R Nemerow
Jan 1, 1993·Methods in Enzymology·G P Smith, J K Scott
Jan 10, 1995·Virology·P Pring-Akerblom, T Adrian
Oct 1, 1994·Journal of Virology·P MathiasG Nemerow
Mar 4, 1994·Journal of Molecular Biology·C D DickinsonK R Ely
Jun 1, 1994·Journal of Virology·N LouisJ Chroboczek

❮ Previous
Next ❯

Citations

Nov 5, 2003·Advanced Drug Delivery Reviews·Lali K Medina-Kauwe
Jul 7, 2005·Vaccine·J PitcovskiB Gutter
Dec 23, 2003·Virus Research·Qiaohua Wu, Suresh Kumar Tikoo
Jun 27, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marianela CandolfiMaria G Castro
May 5, 2000·Biochemical Pharmacology·J M Bergelson
Apr 2, 2003·Pharmacology & Therapeutics·M G CastroP R Lowenstein
Oct 25, 2001·Antiviral Research·H KanekoS Shigeta
Jun 22, 2002·Antiviral Research·Paul J HippenmeyerDavid W Griggs
Sep 26, 2002·Virus Research·Adrienne L McNees, Linda R Gooding
Nov 14, 1997·Current Opinion in Biotechnology·I KovesdiT J Wickham
Oct 6, 1999·Current Opinion in Biotechnology·K BenihoudM Perricaudet
Jun 19, 1998·Current Opinion in Structural Biology·J J Rux, R M Burnett
Apr 20, 2004·Critical Reviews in Oncology/hematology·Frederik H E SchagenRob C Hoeben
Mar 24, 1999·Molecular Medicine Today·P N ReynoldsD T Curiel
Jan 19, 2000·Drug Discovery Today·I Wang, I Huang
Jan 28, 2006·Cancer Gene Therapy·J N GlasgowD T Curiel
Nov 22, 2005·Oncogene·J Michael MathisDavid T Curiel
Sep 22, 1999·European Journal of Biochemistry·A MitrakiR W Ruigrok
Oct 6, 2000·Human Gene Therapy·M TrepelR Pasqualini
Sep 25, 1999·Human Gene Therapy·J P WisniveskyR G Crystal
Oct 6, 1997·The EMBO Journal·U F GreberA Helenius
May 4, 2005·Inflammatory Bowel Diseases·Phyllissa Schmiedlin-RenEllen M Zimmermann
Feb 10, 2000·Annals of the New York Academy of Sciences·D T Curiel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.